Good morning investors,
Hope you all are having a great Q2 earnings season. We are halfway through this busy time of the year and ready to keep rolling as additional incremental information is released.
Going to take the time today to give an overview of the companies in my portfolio and what has happened so far in Q2. But before we get to that, first a word from our sponsor.
Investing in blue-chip wines, seems to most, like an activity for a closed group of wealthy investors. But that is changing.
With the technology platform Vinovest anyone and everyone can now invest in fine and rare wines.
And the best part is, Vinovest works like any other financial services platform, such as Vanguard or Robinhood. But instead of stocks, it is all about wine.
Q2 2021 Update
For subscribers of the premium letter here is a quick overview of what has happened so far. If you are not yet subscribed to the Alpha Letter, you can subscribe using the link below.
Use the links in each bullet point to see the original research if you don’t know what company I am writing about.
Company One: Earnings were pretty much inline with my estimates. Revenues have improved dramatically from 2020 lows and continue to increase going into Q3 (from management’s guidance). The dividend was recently reinstated, giving us a forward yield just shy of 3%. I think the company increases the dividend back to pre-2020 levels over the next couple of quarters, putting the yield closer to 6%. Cash on the balance sheet continues to grow. I think we get back to 2019 revenue and EBITDA levels by the end of 2021. Enterprise value is $80 million with potential to generate $15-20 million in free cash flow per year. Low risk, decent upside idea. Be patient if you are a buyer. The stock is highly illiquid.
Company Two: Earnings were a little disappointing here. Most investors were expecting a $5-7/unit distribution given increased price in fertilizers. But pricing apparently didn’t hit the income statement until later in the quarter, dragging down operating performance. The distribution was still a respectable $1.72/unit and I expect this to grow going into the back half. I reduced my position to add to my new top idea as I think the risk/reward is much more favorable in this new idea.
Company Three: This management team continues to impress me as they have been executing on their strategy. The stock is up over 200% since going public despite all of their peers trading lower. Balance sheet is pristine and the monthly dividend (5.6% yield) is great to receive. The stock is fairly valued at the current price but if additional gold reserves are discovered there is option upside as the terminal value of the company will be extended. I am happy to hold this company at the current price and get paid to wait. In addition, I think of this as a decent inflationary trade given the business they are in.
Company Four: Results were a little better than I had them at but still not back to 2019 levels. The company should be EBITDA positive going into Q3 (first time since the pandemic). In addition, the management team continues to monetize excess real estate and now some life insurance assets which will continue to bolster the balance sheet. Management team is Class A and will continue to create shareholder value. This company’s assets continue to outperform their peers which will be beneficial over the long-term. Happy to hold for at the current price and will continue to buy on any material weakness.
Company Five: This company outperformed my estimates by a wide margin. The market ran the great earnings report and the stock is now up over 60% from my original research report. Fair value is $10-12/share over the mid-term and could possibly go higher over the long-term depending on how management allocates capital in the future. I took this good news and sold my entire position to add to their peer which I wrote up recently. I think their peer is extremely undervalued and should continue to re-rate as positive macro conditions persist.
Company Six: This is my new top idea that I have recently been purchasing and was talking about in the Company Five and Company Two bullet points. I wrote the stock up last Wednesday telling subscribers I was buying the stock hand over fist. The stock is now up over 20%. This is a fairly risky investment as there is a significant amount of debt on the balance sheet, but if I am right and pricing continues to hold over the next few months I think the stock could go to $50/share. As an incremental piece of information, steel producers surged today as the Senate passed its $1 trillion infrastructure bill. This should largely benefit this company due to their close ties to the steel industry.
I am still waiting on the last two companies to report their earnings which is usually at the end of August (please see the research here and here). I think both should post decent results as they are both reopening plays and their peers have reported good results. Will keep you all updated when these earning reports come out.
Disclaimer: The publisher does not guarantee the accuracy or completeness of the information provided in this page. All statements and expressions herein are the sole opinion of the author or paid advertiser.
Alpha Letter is a publisher of financial information, not an investment advisor. We do not provide personalized or individualized investment advice or information that is tailored to the needs of any particular recipient.
THE INFORMATION CONTAINED ON THIS WEBSITE IS NOT AND SHOULD NOT BE CONSTRUED AS INVESTMENT ADVICE, AND DOES NOT PURPORT TO BE AND DOES NOT EXPRESS ANY OPINION AS TO THE PRICE AT WHICH THE SECURITIES OF ANY COMPANY MAY TRADE AT ANY TIME. THE INFORMATION AND OPINIONS PROVIDED HEREIN SHOULD NOT BE TAKEN AS SPECIFIC ADVICE ON THE MERITS OF ANY INVESTMENT DECISION. INVESTORS SHOULD MAKE THEIR OWN INVESTIGATION AND DECISIONS REGARDING THE PROSPECTS OF ANY COMPANY DISCUSSED HEREIN BASED ON SUCH INVESTORS’ OWN REVIEW OF PUBLICLY AVAILABLE INFORMATION AND SHOULD NOT RELY ON THE INFORMATION CONTAINED HEREIN.
No statement or expression of opinion, or any other matter herein, directly or indirectly, is an offer or the solicitation of an offer to buy or sell the securities or financial instruments mentioned.
Any projections, market outlooks or estimates herein are forward looking statements and are inherently unreliable. They are based upon certain assumptions and should not be construed to be indicative of the actual events that will occur. Other events that were not taken into account may occur and may significantly affect the returns or performance of the securities discussed herein. The information provided herein is based on matters as they exist as of the date of preparation and not as of any future date, and the publisher undertakes no obligation to correct, update or revise the information in this document or to otherwise provide any additional material.
The publisher, its affiliates, and clients of the a publisher or its affiliates may currently have long or short positions in the securities of the companies mentioned herein, or may have such a position in the future (and therefore may profit from fluctuations in the trading price of the securities). To the extent such persons do have such positions, there is no guarantee that such persons will maintain such positions.
Neither the publisher nor any of its affiliates accepts any liability whatsoever for any direct or consequential loss howsoever arising, directly or indirectly, from any use of the information contained herein.